Researchers Discover Existing Drugs May Prevent Enlarged Hearts

DALLAS -- April 17, 1998 -- Using two drugs already available, researchers at UT Southwestern Medical Center at Dallas may have found a cure for a condition that puts 5 million Americans at risk for sudden death -- an enlarged heart, or cardiac hypertrophy.

In groundbreaking research Dr. Eric Olson, chairman of molecular biology and oncology, and his colleagues discovered a molecular pathway that leads to heart enlargement and have found a way to block that pathway using an immunosuppressant drug already approved by the Food and Drug Administration, although not for that condition. Their study, published in the April 17 issue of Cell, was done in mice whose progression from cardiac hypertrophy to heart failure to death mirrored humans'.

"Cardiac hypertrophy is the response of the heart to all sorts of damage, like hypertension or heart attacks or endocrine disorders or mutations. What the heart does is try to compensate for that damage by increasing its size to achieve greater cardiac output," said Olson.

Initially this is beneficial, but ultimately the heart may enlarge too much, causing congestive heart failure that can lead to sudden death. Half of cardiac hypertrophy patients die from the condition.

Olson and his research team showed that cardiac hypertrophy is controlled by a single protein, calcineurin, which acts as a gatekeeper to the cells nucleus, the control room where specific molecules regulate gene function. When stimulated by a sustained increase in the cells calcium level, calcineurin activates its target protein, NFAT3, which then enters the nucleus and turns on the genes that cause heart enlargement.

The researchers genetically engineered two strains of mice to test their hypotheses. One strain continually expressed activated calcineurin in heart muscle cells, which allowed activated NFAT3 to enter the nucleus and start the hyper

Contact: Heather Stieglitz
(214) 648-3404
UT Southwestern Medical Center

Page: 1 2 3

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:

(Date:8/12/2020)... ... August 12, 2020 , ... ... systems that are ideal for public health agencies of all sizes. With a ... and helping at-risk individuals find appropriate health care, Mosio helps public health departments ...
(Date:8/3/2020)... ... August 03, 2020 , ... Accumen Inc. is helping ... equipment manufacturer, Spectrum Solutions, to provide COVID-19 saliva testing kits nationally. , ... for more than 10 years. Early in the COVID-19 crisis, we identified supply ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been ... Medical Neoasis™ active noise control device to attenuate typical noises in a simulated ... attenuated the alarm sounds from patient monitors, ventilators and other bedside devices that ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... ... After research model surgery and catheter implantation, the long journey of catheter ... of a successful study, while protecting and accessing the catheter or device post-surgery is ... from Envigo in a live webinar on Wednesday, August 5, ...
(Date:7/10/2020)... ... July 09, 2020 , ... PathSensors ... (MIT) has expanded the company’s exclusive license to include clinical applications for ... diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast and ...
(Date:7/1/2020)... ... June 29, 2020 , ... MedShift , ... in 2020, despite many obstacles created as a result of COVID-19. As a ... its partnered medical practices and medical manufacturers by expanding access to device offerings, ...
(Date:6/28/2020)... HILL, Conn. (PRWEB) , ... June 25, 2020 ... ... company formed to advance photodynamic therapy for treating cancer, today announced the company ... New York (“Roswell Park”). The agreement provides Lumeda globally exclusive rights to ...
Breaking Biology Technology:
Cached News: